摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzyl N-[(2S)-4-methyl-1-[7-[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]-3,7-diazabicyclo[3.3.1]nonan-3-yl]-1-oxopentan-2-yl]carbamate | 1357257-64-7

中文名称
——
中文别名
——
英文名称
benzyl N-[(2S)-4-methyl-1-[7-[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]-3,7-diazabicyclo[3.3.1]nonan-3-yl]-1-oxopentan-2-yl]carbamate
英文别名
——
benzyl N-[(2S)-4-methyl-1-[7-[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]-3,7-diazabicyclo[3.3.1]nonan-3-yl]-1-oxopentan-2-yl]carbamate化学式
CAS
1357257-64-7
化学式
C35H48N4O6
mdl
——
分子量
620.789
InChiKey
OGRQYTPWNXGMHE-NPYONTDKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    156-157 °C
  • 沸点:
    800.6±65.0 °C(predicted)
  • 密度:
    1.169±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    45
  • 可旋转键数:
    14
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    117
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • Modulation of prion polymerization and toxicity by rationally designed peptidomimetics
    作者:Ankit Srivastava、Sakshi Sharma、Sandhya Sadanandan、Sakshi Gupta、Jasdeep Singh、Sarika Gupta、V. Haridas、Bishwajit Kundu
    DOI:10.1042/bcj20160737
    日期:2017.1.1

    Misfolding and aggregation of cellular prion protein is associated with a large array of neurological disorders commonly called the transmissible spongiform encephalopathies. Designing inhibitors against prions has remained a daunting task owing to limited information about mechanism(s) of their pathogenic self-assembly. Here, we explore the anti-prion properties of a combinatorial library of bispidine-based peptidomimetics (BPMs) that conjugate amino acids with hydrophobic and aromatic side chains. Keeping the bispidine unit unaltered, a series of structurally diverse BPMs were synthesized and tested for their prion-modulating properties. Administration of Leu- and Trp-BPMs delayed and completely inhibited the amyloidogenic conversion of human prion protein (HuPrP), respectively. We found that each BPM induced the HuPrP to form unique oligomeric nanostructures differing in their biophysical properties, cellular toxicities and response to conformation-specific antibodies. While Leu-BPMs were found to stabilize the oligomers, Trp-BPMs effected transient oligomerization, resulting in the formation of non-toxic, non-fibrillar aggregates. Yet another aromatic residue, Phe, however, accelerated the aggregation process in HuPrP. Molecular insights obtained through MD (molecular dynamics) simulations suggested that each BPM differently engages a conserved Tyr 169 residue at the α2–β2 loop of HuPrP and affects the stability of α2 and α3 helices. Our results demonstrate that this new class of molecules having chemical scaffolds conjugating hydrophobic/aromatic residues could effectively modulate prion aggregation and toxicity.

    细胞朊病毒蛋白的错误折叠和聚集与一系列神经系统疾病有关,这些疾病通常被称为传染性海绵状脑病。由于有关朊病毒致病自组装机制的信息有限,设计朊病毒抑制剂一直是一项艰巨的任务。在这里,我们探讨了基于双脒的拟肽化合物(BPMs)组合库的抗朊病毒特性,该化合物将氨基酸与疏水侧链和芳香侧链结合在一起。在保持双脒单元不变的情况下,合成了一系列结构多样的 BPM,并对其朊病毒调节特性进行了测试。服用 Leu- 和 Trp-BPMs 可分别延迟和完全抑制人朊病毒蛋白(HuPrP)的淀粉样转化。我们发现,每种BPM都能诱导HuPrP形成独特的低聚物纳米结构,其生物物理特性、细胞毒性和对构象特异性抗体的反应各不相同。研究发现,Leu-BPM 可稳定低聚物,而 Trp-BPM 则可实现瞬时低聚,从而形成无毒的非纤维状聚集体。然而,另一种芳香族残基 Phe 会加速 HuPrP 的聚集过程。通过 MD(分子动力学)模拟获得的分子见解表明,每一种 BPM 都以不同的方式与 HuPrP α2-β2 环上的保守 Tyr 169 残基结合,并影响 α2 和 α3 螺旋的稳定性。我们的研究结果表明,这一类新分子具有连接疏水/芳香残基的化学支架,可有效调节朊病毒的聚集和毒性。
  • Bispidine as a secondary structure nucleator in peptides
    作者:V. Haridas、Sandhya Sadanandan、Yogesh K. Sharma、Srinivas Chinthalapalli、Ashutosh Shandilya
    DOI:10.1016/j.tetlet.2011.11.112
    日期:2012.2
    Here we describe bispidine as a scaffold for inducing open turn-like and beta sheet conformations on the attached peptides depending on the mode of attachment of peptides to the scaffold. Various bispidine-peptide conjugates were designed and synthesized to demonstrate the versatility of the scaffold. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物